Walleye Capital’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.21M Buy
94,200
+91,000
+2,844% +$5.17M ﹤0.01% 2080
2026
Q2
$254K Buy
3,200
+1,700
+113% +$128K ﹤0.01% 3315
2026
Q1
$113K Sell
1,500
-9,400
-86% -$742K ﹤0.01% 3624
2025
Q4
$862K Buy
10,900
+5,400
+98% +$407K ﹤0.01% 2562
2025
Q3
$360K Buy
5,500
+1,100
+25% +$53.7K ﹤0.01% 2863
2025
Q2
$174K Sell
4,400
-11,100
-72% -$363K ﹤0.01% 3465
2025
Q1
$468K Sell
15,500
-13,000
-46% -$426K ﹤0.01% 2624
2024
Q4
$996K Buy
28,500
+22,100
+345% +$826K ﹤0.01% 2397
2024
Q3
$256K Sell
6,400
-31,200
-83% -$1.45M ﹤0.01% 3826
2024
Q2
$1.79M Buy
37,600
+34,300
+1,039% +$1.41M ﹤0.01% 2215
2024
Q1
$143K Sell
3,300
-5,300
-62% -$253K ﹤0.01% 4181
2023
Q4
$435K Sell
8,600
-13,000
-60% -$623K ﹤0.01% 3060
2023
Q3
$980K Sell
21,600
-8,100
-27% -$334K ﹤0.01% 2268
2023
Q2
$1.22M Buy
29,700
+9,800
+49% +$377K ﹤0.01% 1687
2023
Q1
$711K Buy
+19,900
New +$747K 0.01% 1406
2020
Q1
– Sell
-100
Closed -$6K – 1283
2019
Q4
$6K Sell
100
-800
-89% -$47.7K ﹤0.01% 1671
2019
Q3
$54K Sell
900
-2,100
-70% -$137K ﹤0.01% 1587
2019
Q2
$193K Buy
3,000
+2,400
+400% +$170K 0.02% 984
2019
Q1
$49K Buy
+600
New +$38.7K 0.01% 1212

Other funds holding IONS

Walleye Capital's IONS Position: Q3 2026 in Review

Walleye Capital increased its Ionis Pharmaceuticals (IONS) stake by 4,551,400% in Q3 2026, buying an estimated $5.17M and bringing the position to 91,030 shares worth $4.06M. The position accounts for ﹤0.01% of the portfolio, ranked #2113.

Walleye Capital first reported a position in IONS in Q1 2019 and has held it in 17 quarters since. The position peaked at $4.97M in Q3 2024. 465 funds tracked by Wall St. Rank hold IONS as of Q3 2026.

  • Walleye Capital held 91,030 shares of Ionis Pharmaceuticals worth $4.06M as of Q3 2026.
  • Walleye Capital bought 91,028 Ionis Pharmaceuticals shares in Q3 2026, an estimated $5.17M.
  • Ionis Pharmaceuticals made up ﹤0.01% of Walleye Capital's portfolio in Q3 2026, its #2113 holding.
  • Walleye Capital first reported a position in Ionis Pharmaceuticals in Q1 2019 and has held it in 17 quarters since.
  • Walleye Capital's Ionis Pharmaceuticals position peaked at $4.97M in Q3 2024.
  • 465 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.

Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.